BioCentury
ARTICLE | Company News

Palatin, Competitive Technologies Inc. genitourinary news

June 27, 2005 7:00 AM UTC

The companies settled their previously announced arbitration related to a 1997 license agreement for PTN to exclusively use CTT's Erectide peptide hormone analog in PTN's PT-141 erectile dysfunction ...